Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ali Ataya

Pulmonary Vascular Med · UF

View

Dr. Naftali Kaminski

Interstitial Lung Disease · Yale College

View

Dr. Auston Stiefer

Interstitial Lung Disease · CU Anschutz Medical Campus

View

Dr. Justin Zhang

Critical Care · UCLA

View

Dr. Panagis Galiatsatos

Critical Care · Johns Hopkins

View

Dr. MeiLan Han

Asthma & COPD · UMHS

View

Dr. Kevin Chung

Critical Care · SeaStar Medical

View

Dr. Diego J. Maselli

Asthma & COPD · UTHSCSA

View

Dr. Amos E. Dodi

Critical Care · MMC

View

Dr. Imre Noth

Interstitial Lung Disease · University of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Right Heart Diastology, Where Are We Now?

    May 21, 2026DOI: 10.1161/circresaha.125.327196Journal ArticleAHA

    Written by: Christopher J KocxAnna R HemnesJames HealyDavid M KayeFrançois F HaddadSean LalDavid S Celermajer

    Find these authors on Roon

    AH
    Dr. Anna Hemnes
    Pulmonary Vascular Med · Vanderbilt

    Foundational Physiology and Anatomy

    Most commonly, RV diastole is defined as the period from pulmonic valve closure to tricuspid valve (TV) closure.6 However, different definitions exist depending on the reference framework used, utilizing either mechanical, hemodynamic, valve, or electrocardiographic markers.6–9 For example, TV closure is known to occur after RV contraction has already begun, during the isovolumic contraction phase, highlighting one such discrepancy between valve and contraction-based definitions of end-diastole.8–10 This complicates the standardization of measurement.9,10 For the purposes of this review, RV diastole spans from pulmonic valve closure to the subsequent TV closure, with distinct phases.6,9 This section outlines the mechanical phases of RV diastole, the underlying P-V relationships, and the features that distinguish RV from LV filling (Table 1).Key Anatomic and Physiological Differences Between Right Ventricular and LV DiastoleWhen the pulmonic valve and TV close, the RV myocardium actively relaxes (lusitropy), and intraventricular pressure falls rapidly.6 This is an energy-dependent process requiring Ca2+ reuptake from the cytosol into the sarcoplasmic reticulum.6,11 In early RV diastole, relaxation is the dominant determinant of filling efficacy. Isovolumic relaxation (IVR) in a healthy RV is brief, as systolic pressure is relatively low and falls below RA pressure quickly.RV pressure drops below RA pressure, opening the TV and presaging passive RV filling. During this phase, the RV acts as a suction pump; continued myocardial relaxation and elastic recoil facilitate brisk filling.6 Approximately two-thirds of RV stroke volume fills during this early phase under resting conditions.6As RA and RV pressures equalize, mid-diastole sees a phase of slow filling (diastasis). Diastasis duration is inversely dependent on heart rate.8 During diastasis, venous return is temporarily balanced by RV filling such that little net volume enters the RV and the transtricuspid gradient is near zero.6In late diastole, RA contraction augments RV filling, with its relative contribution increasing at higher heart rates or when ventricular compliance is reduced.6,7,12 RA reservoir and booster-pump phases reflect atrial contractile function and correlate with RA pressure (RAP), RV diastolic properties, and surrogate metrics predict outcomes.2,13 These findings support the importance of atrial systole, particularly when RV compliance is reduced.14 Conversely, loss of synchronous atrial contraction (eg, atrial fibrillation) impairs RV filling, especially when the ventricle is noncompliant.6There are distinct differences between the LV and the RV P-V loop and thus in fundamental diastolic parameters (Figure 1A and 1B).9Right ventricular (RV) and right atrial (RA) pressure-volume (P-V) loops A, Left ventricle (LV) P-V loop typical appearance with resting conditions. B, RV P-V loop typical appearance with resting conditions. C, Stiff RV with elevated β and RV end-diastolic pressure (RVEDP), prolonged isovolumic relaxation time (IVRT) constant (Tau), reduced compliance, and stroke volume. Loop shifted up and left. D, Normal RA P-V loop appearance. E, Stiff RV RA P-V loop appearance. F, Uncoupled RA P-V loop appearance. Blue=reservoir phase, green=conduit phase, and red=booster phase. AV indicates aortic valve; EDPVR, end-diastolic pressure-volume relationship; Eed indicates end-diastolic elastance; Ees, end-systolic elastance; ESPVR, end systolic pressure-volume relationship; IVCT, isovolumic contraction time; LVEDP, left ventricular end diastolic pressure; LVESP, left ventricular end systolic pressure; MV, mitral valve; PV, pulmonic valve; RAP, right atrial pressure; RVESP, right ventricular end-systolic pressure; and TV, tricuspid valve.RAP is a measure of RV filling pressure and preload.15 Normal values are 1 to 5 mm Hg.15 In steady state, without tricuspid regurgitation, venous return equals cardiac output, and RAP adjusts to allow equilibrium.16 RV end-diastolic pressure (RVEDP) is measured at the end of RA systole (point of maximal RV filling).17 Normally, low (2–6 mm Hg), RVEDP rises when the RV is volume-overloaded or noncompliant.15 An RVEDP approaching or exceeding 10 to 12 mm Hg is abnormal and correlates with signs of congestion.15,17The end-diastolic P-V relationship (EDPVR, β) describe an exponential relationship between chamber pressure during diastole and passive mechanical properties of the ventricle.6,18 The slope of this curve at any given volume represents chamber stiffness.6,18 This increases as the RV approaches end-diastole and is commonly expressed as the stiffness constant β.4,6 In invasive physiology studies, the EDPVR is typically modeled using an exponential equation of the form P=α×(eβV−1), where β quantifies the steepness of the P-V rise, and α is a curve-fitting constant.6,9,18Isovolumic relaxation time constant (Tau) is an index of RV IVR, defined by the exponential decay of pressure in early diastole.12,19 Although traditionally described for the LV, Tau can be derived for the RV using the same principles, by fitting the early diastolic pressure decline to a monoexponential function, typically of the form P(t)=P0×e(−t/Tau).18,19 Tau prolongation reflects slowed IVR kinetics (impaired lusitropy) rather than reflecting altered myocardial energetics.18,19 As Tau increases, the RV is slower to relax, and therefore, the IVR period is extended. This contributes to a higher RA/RV pressure at the time of tricuspid opening, thus reducing early filling velocities and impairing early diastolic filling.8,14,18,19The RV is relatively thin-walled and crescent-shaped, wrapping around the LV.20 The RV myocardium has 2 layers (superficial circumferential and deep longitudinal) rather than the 3 layers of the LV.17,20 Both contribute to higher RV compliance than the LV at normal filling pressure.6,17Normal RA pressures are lower than normal left atrial pressures. Consequently, normal RV filling occurs at lower absolute pressures. This low-pressure system makes RV filling more dependent on changes in intrathoracic pressure and external constraints, compared with the thicker-walled LV (in health).20 This contrasts with the LV, which operates at higher filling pressures and is comparatively less influenced beat-to-beat by respiration.5,17Compliance (the inverse of stiffness) defines the ventricle’s capacity to accommodate volume.5,17 Unlike the rectangular LV P-V loop, the RV exhibits a characteristic triangular profile reflecting low afterload and minimal isovolumic contraction (Figure 1B).9 Importantly, the healthy RV operates on the flat, highly compliant limb of its diastolic P-V curve (Figure 1A).6 However, this reserve is finite, and with either inherent stiffening or extrinsic influence, effective stiffness can rapidly increase.21,22 Consequently, architectural distortion or volume-overload shifts the operating point to the steep portion of the curve, precipitating sharp pressure rises.16,22Both ventricles exhibit active relaxation; however, the structure of the LV enables untwisting simultaneously with longitudinal motion, which creates a suction effect that markedly reduces LV pressure in early diastole.23,24 By contrast, RV filling was thought to be driven primarily by elastic recoil of its free wall in a longitudinal direction without a significant torsional component to generate diastolic suction.23,25 However, recent experimental and imaging evidence suggests this likely underestimates a key role played by the RV portion of the interventricular septum, and thus septal twist mechanics play a key role alongside longitudinal motion.21,22 Disruption of this function (eg, from surgical injury or ischemia) can impair RV performance even in the presence of an intact RV free wall, underscoring the septum’s dynamic role in biventricular mechanics.22RV diastolic compliance is influenced not only by intrinsic myocardial properties but also by extrinsic factors such as the fibrous pericardium and the higher-pressure LV, with which the RV shares a wall (the interventricular septum).5,17 At rest, the pericardium operates in a relatively flat portion of its P-V curve, allowing some reserve capacity for the RV.5,17,26 However, during increased end-diastolic volume (eg, volume loading), the pericardium becomes more stretched and resists further expansion, leading to increased pericardial pressure.5,17,26 This may limit filling, creating diastolic interdependence with the LV.26,27 Epicardial adipose tissue (EAT), concentrated over the RV free wall between myocardium and visceral pericardium, may augment pericardial restraint and worsen RV diastolic function.28 Whether EAT acts primarily via mechanical constraint or paracrine signaling remains unresolved. The interventricular septum also plays a key role in diastolic interdependence. Driven by trans-septal gradients, the septum shifts toward the lower-pressure chamber, manifesting as diastolic flattening in volume-overload and systolic flattening in pressure-overload, thereby compromising the filling of the opposing ventricle.5,17 Thus, pericardial constraint and ventricular interdependence critically influence RV diastology and filling.

    Right Heart Coupling Axes, Understanding the Diastolic Unit (RA-RV-PA)

    The RA adapts to downstream disease (ie, rising RV pressure and stiffness) through 3 measurable dimensions: pressure, size, and phasic function. The RA modulates preload to the RV through reservoir, conduit, and booster-pump phases (Figure 1D). Although the mechanics are well established, the unresolved issue is which phasic alteration(s) carry prognostic relevance and whether these vary across disease states.1,13 The RA-RV-PA diastolic unit framework defined in introductory paragraphs positions RA phasic function as a clinical window into this coupling relationship.The RA both reflects RV filling conditions, acting as a functional barometer of RV diastolic stress.13,29,30 With normal compliance, it augments RV preload while operating at low pressure (Figure 1D).17 As RV pressure and stiffness rise, the RA responds with increased stroke work to provide compensatory RV filling (Figure 1E).30,31 Single-cardiomyocyte analyses demonstrate that this augmented stroke work derives from cardiomyocyte hypertrophy rather than enhanced sarcomeric contractility; active force, passive force, and calcium sensitivity remain unchanged.31 This geometric rather than contractile response supports translational approaches using volumetric assessment to track RA remodeling noninvasively. With progressive RV stiffening, RA dilation and stiffness culminate in RA-RV uncoupling, heralded by deteriorating reservoir and booster function (Figure 1F).30,31 However, the precise pathophysiological sequence remains incompletely characterized.The potential early sensitivity of RA functional change to RV stiffness underlies the proposed utility of more detailed RA assessment.29 The prognostic impact of RA metrics (typically RAP) measured both invasively and noninvasively has been demonstrated in small, disease-specific cohorts.32,33 Emerging imaging and invasive data suggest that RA enlargement and abnormalities of phasic function typically precede, or parallel, reduced RV compliance and rising RVEDP, positioning them as early markers of diastolic dysfunction.1,33–36 In pulmonary arterial hypertension (PAH), RA dilation and loss of reservoir/booster-pump function are associated and track rising RAP and RVEDP, as well as prognostically relevant clinical end points.1,2,13 These insights are supported by invasive validation and are beginning to be reflected in contemporary guidelines and risk algorithms.13,29 The incremental prognostic value of RA functional assessment over established RV assessment has not been demonstrated, limiting adoption in formal risk models.13,30The RA is intrinsically exposed to chamber interdependence because of a shared interatrial septum and the surrounding pericardium. The same principles that govern ventricular interdependence shape the relationship between RA and RV filling pressures, as interdependence is not limited to the ventricles. When left atrial pressure is high, as in HF with preserved ejection fraction (HFpEF) and postcapillary pulmonary hypertension (PH), the interatrial septum shifts toward the RA, exerting mild compression unless RAP is similarly elevated.29,37 This can blunt early RA enlargement or phasic change, complicating interpretation of RA functional metrics as pure markers of RV diastolic load; the prevalence, magnitude, and clinical impact of such atrial interdependence remain largely unexplored.29,37The thin-walled RV normally operates with Ees (≈0.8 mm Hg/mL) exceeding Ea (≈0.5 mm Hg/mL). Their ratio (Ees/Ea ≈1.5–2.0) defines the efficiency of converting contractile work into forward flow.20 Because Ea integrates pulmonary vascular resistance and PA compliance, even modest afterload rises narrow the RV P-V loop and increase diastolic wall stress.17 Thus, although conceived as a systolic efficiency index, Ees/Ea is indirectly linked to diastolic load.38 Its major limitation remains practicality. Accurate determination requires invasive P-V loops, and noninvasive surrogates show variable validity across cohorts as well as poor standardization across pathologies.In health, exercise raises Ees disproportionately to Ea, driving Ees/Ea upward, preserving stroke work at peak cardiac output.39–41 In athletes with prolonged training-induced pressure loading, RV hypertrophy develops while resting coupling remains preserved, and the healthy RV remains compliant.39,42 This adaptation is hypothesized to occur without pathological stiffening (see Microscopic Understanding of Diastole and Difference Between Ventricles) that would increase β with pressure loading, though direct invasive confirmation in this population is lacking. Furthermore, this adaptation has limits; chronic loading may exceed a threshold that promotes fibrosis and the development of arrhythmogenic substrate in a subset of athletes.42,43 Fundamentally, this highlights how resting Ees/Ea may appear normal even when physiological reserve is reduced, and even physiological RV adaptation to loading is heterogeneous across healthy cohorts. Vulnerability resides in this loss of reserve (see RA as a Right Heart Diastolic Barometer).30,31Increases in Ea shift the RV P-V loop upward and rightward, significantly prolonging Tau, and elevating RVEDP before ejection fraction begins to fall.3 Tau and β exhibit a near-linear inverse relationship with Ees/Ea, and once the ratio drops below ≈1.0, diastolic indices deteriorate rapidly.44 In a high-afterload pulmonary circulation, increased proximal arterial stiffness generates earlier, higher-amplitude reflected pressure waves, augmenting late-systolic and early diastolic RV load and thereby elevating RVEDP and impairing ventricular relaxation.45,46 This afterload-driven diastolic impairment is consistent across phenotypes, but timing differs. Classical idiopathic PAH with no parenchymal disease maintains RV-PA coupling longer, whereas smoking-related low-diffusing capacity for carbon monoxide PAH resembles Group 3 PH with earlier stiffening and worse outcomes.47 This single example highlights a central challenge, with similar resting hemodynamics concealing divergent diastolic trajectories. Therefore, RA behavior, directly responding to rising RVEDP and diastolic load, may differentiate phenotypes earlier than purely RV-centric indices.Acute reductions in afterload, via inhaled NO or PDE-5 (phosphodiesterase-5) inhibition, lower Ea by ≈25%, restore Ees/Ea toward ≈1.5, reduce RAP by 3 to 5 mm Hg, and shorten Tau in patients with PAH.38 Chronic endothelin-receptor antagonism similarly improves coupling while lowering β, underscoring that coupling restoration involves diastolic parameters.4,48 In chronic thromboembolic PH (CTEPH), balloon pulmonary angioplasty produces reverse remodeling with measurable improvement in RA reservoir and conduit function.49 Therapeutic signals continue to emerge from diverse clinical cohorts, and a key translational priority moving forward will be the formulation and validation of existing markers to reliably track coupling restoration and diastolic improvement.We think that the RA-RV-PA diastolic unit is physiologically distinct from conventional RV-PA coupling (Ees/Ea) in one critical respect, in that it incorporates RA signals. Existing coupling paradigms quantify the systolic efficiency of energy transfer between the ventricle and pulmonary vasculature but are, by definition, insensitive to the upstream preload compartment. This diastolic unit framework recognizes the RA functions as a barometer of rising RV diastolic stress, augmenting stroke work through geometric remodeling before resting Ees/Ea deteriorates and before systolic indices fall, rendering the atrial signal physiologically distinct from ventricular-level assessment. This positions RA functional change at a potentially earlier and more reversible point on the remodeling trajectory than ventricular uncoupling, which in turn has potential implications for earlier therapeutic intervention. Practically, this has 3 implications which require investigation and prognostic validation. First, for study design, it argues that RA phasic metrics should be incorporated alongside RV-PA coupling indices as end points rather than as secondary descriptors. Second, for phenotyping, it offers a mechanism to differentiate disease states that share similar resting hemodynamics but follow divergent diastolic trajectories (see Rising Afterload Translates Into Increased Diastolic Burden). Third, for clinical interpretation, serial RA functional assessment (as outlined specifically in sections Imaging Toolkit: Current State of Validation for Available Noninvasive Measures, Applying Right Heart Diastology to Human Health and Disease, and Future Directions below) may track diastolic unit failure and coupling restoration with therapy, complementing existing metrics that capture afterload relief.

    Microscopic Understanding of Diastole and the Difference Between Ventricles

    Having outlined macroscopic chamber interactions, we now examine the cellular and molecular determinants of RV relaxation and stiffness. Embryological divergence between the left and RVs generates persistent chamber-specific molecular profiles that shape diastolic behavior. Human proteomic and metabolomic studies confirm distinct metabolic and structural signatures in RV versus LV myocardium, supporting the need for ventricle-specific analysis of diastolic mechanics.50 PAH serves as the principal translational model, explaining why the strongest human signals cluster in PAH cohorts. We grade emerging mechanistic evidence into 3 tiers (Table 2): Validated (supported by direct human RV tissue evidence with mechanistic linkage to diastolic stiffness or filling), supported (human RV signals with incomplete causal chain or end-stage sampling bias), and inferred (preclinical models or human LV extrapolation without direct human RV confirmation).Mechanistic Determinants of RV Diastolic Dysfunction: Hierarchy of EvidenceFibrosis and ECM (extracellular matrix) remodeling are structural correlates of RV diastolic dysfunction in PAH. Human histology confirms fibrosis correlates with invasively assessed chamber stiffness, though absolute collagen increases are often modest, suggesting a disproportionate functional impact.44,51 Notably, fibrosis is also regionally heterogeneous, clustering at ventricular insertion points, secondary to the mechanical stress of septal displacement.51 The invasive stiffness metrics (β, end-diastolic elastance [Eed]) track filling pressures and have prognostic significance in PAH cohorts.52 Preclinical models (ie, PA banding, monocrotaline, Su-Hx [Sugen5416/hypoxia]) parallel these findings (see Load Phenotypes and Mechanistic Trajectories). Mechanistically, fibrosis primarily alters passive diastolic properties (β, Eed), whereas effects on active relaxation (Tau) appear indirect and context dependent.44,52 Unfortunately, available data is cross-sectional in nature. Thus, fibrosis may represent a driver, amplifier, or downstream marker of remodeling, and longitudinal RV tissue studies linked to contemporaneous diastolic phenotyping remain unavailable. The link between fibrosis and stiffness is supported by direct human RV tissue data in PAH, reproducible across preclinical paradigms, but remains disease-specific rather than broadly generalizable. Its prognostic relevance in non-PAH phenotypes remains inferred, and its causal directionality unresolved without longitudinal tissue-level studies.Titin provides passive elastic recoil and determines sarcomere stiffness.53 Excessive titin stiffness increases passive tension and raises diastolic chamber pressures.54 The balance of titin isoforms, N2B (stiffer) and N2BA (more compliant), modulates diastolic myocardial stretch.54,55 The RV expresses a higher N2BA:N2B ratio than the LV across species, although limited quantitative data confirms this in human hearts.56 This differential expression of titin isoforms facilitates greater compliance at low filling pressures based on LV tissue in mouse models.55–57 Furthermore, LV pressure-overload in aortic stenosis is associated with a reduced N2BA/N2B ratio and increased passive stiffness, supporting a hypothesis that lower RV afterload preserves a more compliant titin profile while the LV, conditioned by systemic pressure, shifts toward a stiffer profile.58 Preclinical models demonstrate the RV undergoes adaptive, load-induced, titin isoform shifts toward titin stiffening in both volume- (rodent) and pressure-overload (porcine, CTEPH) models.59,60 This has not been corroborated with human myocardial analysis of PAH, and so isoform shifting does not explain human RV myocardial stiffness.44 Titin hypophosphorylation (of the N2B element specifically) is well established in LV diastolic dysfunction and has been demonstrated to mediate cardiomyocyte stiffness in small PAH RV biopsy cohorts.53,61,62 Titin phosphorylation patterns appear to differ between ventricles, based on rodent models.63 This difference may extend to kinase responsiveness with experimental modulation of passive stiffness and tension, demonstrating differential efficacy.63 Such differential kinase sensitivity suggests RV-specific therapeutic targets for modulating diastolic stiffness may exist.Titin also serves as a critical node for mechanotransduction, with distinct domains activating specific signaling pathways, and posttranslational modifications potentially linking cellular stiffening to macroscopic hemodynamic alteration.54 The N2B element interacts with FHL proteins, a pathway primarily associated with the hypertrophic response to volume overload.64 In contrast, the N2BA element recruits MARP (muscle ankyrin repeat proteins), a pathway hypothesized to drive the trophic response to pressure overload.65 Given constitutive RV N2BA expression, the N2BA-MARP axis may be particularly relevant to RV pressure adaptation, distinguishing it from LV-centric mechanisms.66 Overall, isoform switching is reproducible preclinically but unconfirmed in human RV tissue. Whereas N2B hypophosphorylation is supported as a mediator of passive stiffness in small human PAH biopsy cohorts. Pathophysiological relevance beyond PAH and the therapeutic potential of ventricle-specific kinase sensitivity remain speculative.β-adrenergic signaling modulates diastolic function through phosphorylation of sarcomeric and calcium-handling proteins. PKA (protein kinase A) activation accelerates relaxation by phosphorylating troponin-I (reducing myofilament calcium sensitivity), MyBP-C (myosin-binding protein-C; accelerating cross-bridge cycling), and titin (reducing passive stiffness).53,67,68 Blunted signaling in heart failure (HF) leads to Tn-I (Troponin-I) and MyBP-C hypophosphorylation, prolonged calcium binding, and delayed relaxation.69 In human PAH RV cardiomyocytes, reduced PKA-mediated phosphorylation of titin directly increases passive stiffness and is reversed after PKA incubation (mimicking β-adrenergic receptor signaling).62 Furthermore, in experimental PAH, restoration of β-adrenergic signaling via bisoprolol treatment significantly reduced RV diastolic stiffness (lowered β, Eed) and improved filling, providing in vivo confirmation that recovering this signaling pathway improves diastolic mechanics.70 Therefore, blunted β-adrenergic signaling is supported by convergent human cardiomyocyte and preclinical in vivo evidence in PAH, with a demonstrated causal chain from PKA-mediated titin hypophosphorylation to reversible passive stiffness. However, it remains supported in only a single disease phenotype and has not been tested as a diastolic-specific therapeutic target in clinical trials.Active myocardial relaxation is governed by MyHC (myosin heavy chain) isoform properties and ATP-dependent cross-bridge detachment kinetics, processes that directly determine the relaxation time constant Tau.71 First, isoforms exhibit distinct properties; α-MyHC exhibits higher ATPase activity and faster cross-bridge cycling than β-MyHC.72 Human ventricles predominantly express β-MyHC (>90%), with minimal baseline chamber differences.73 In end-stage LV failure and with aging, α-MyHC to β-MyHC isoform shifts occur, slowing cross-bridge turnover.74,75 RV tissue from patients with HF with reduced ejection fraction–PH provides human evidence of this isoform shift with pressure loading.76 These findings have not been reproduced in alternate cohorts (ie, PAH), limiting generalizability. Preclinical evidence is mixed, chronic pressure loading in rodent models results in significant α-to-β MyHC shifts however is poorly translated as rodent myocardium predominantly expresses a-MyHC.77 Mechanistic models with biochemical myocardial similarity to human tissue (in this case bovine) fail to replicate this switch with RV pressure-overload.78 Based on current evidence, isoform switching is a supported mechanistic pathway for abnormal RV relaxation properties, however, remains cause-dependent rather than a universal response.Second, complete relaxation requires not only cross-bridge detachment (ATP-dependent) but also transition of detached myosin heads from the disordered relaxed state (which remains available for actin binding) to the super relaxed state (functionally quiescent).71,79 This disordered-relaxed and super-relaxed myosin states equilibrium modulates both systolic reserve and diastolic function. Despite significant disordered-relaxed and super-relaxed myosin states dysregulation in decompensated human RV myocytes, single-myocyte passive stiffness remains preserved, contrasting with porcine LV data, where super-relaxed myosin state stabilization increases passive stiffness, leaving chamber-level diastolic implications uncertain.76,79 Determining whether these molecular deficits manifest as chamber-level stiffness (increased β) or impaired relaxation (prolonged Tau) represents a priority for translational assessment.Overall, MyHC isoform shifting is supported by limited human RV data in HF with reduced ejection fraction–PH, but is cause-dependent, poorly reproduced across species, and absent in PAH. Although disordered-relaxed and super-relaxed myosin state dysregulation is confirmed in decompensated human RV myocytes, it has not been linked to chamber-level diastolic impairment. Thus, both pathways are mechanistically plausible and supported but translationally unresolved.RV metabolic remodeling contributes to diastolic dysfunction through several interconnected mechanisms, largely demonstrated in small animal preclinical models. Murine PAH models suggest that a reduction in fatty acid oxidation may cause lipotoxicity and mediate RV myocardial dysfunction.80 Lipid accumulation occurs disproportionately in the RV, with Western diet–induced steatosis prolonging Tau and promoting lipotoxic ceramide accumulation, again in murine models.81 Human studies corroborate these findings by inference, with magnetic resonance spectroscopy revealing RV lipotoxicity and Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) demonstrating increased glucose uptake reflecting characteristic substrate shift from fatty acid to glucose oxidation.80,82 Interventions targeting metabolic pathways show therapeutic promise; for example, metformin prevents diet-induced RV steatosis and improves diastolic relaxation in rodent models.81 However, diastolic metrics are rarely used as primary end points in clinical studies, and human RV-specific data remain limited, constraining translation of these emerging preclinical findings. EAT represents an additional potential metabolic-paracrine modulator of RV diastolic function. EAT sits directly on the RV free wall, sharing coronary-derived microcirculation without an intervening fascial barrier, establishing conduits for local signaling.83 In human LV (specifically HFpEF), EAT expansion results in secretome shifts toward factors which drive fibrosis, impaired fatty acid oxidation, and depressed SERCA2a (sarco/endoplasmic reticulum Ca2+-ATPase 2a) expression.84 EAT-driven inflammation may favor titin hypophosphorylation (see Titin Isoforms and Passive Elasticity [Validated]).85 Greater EAT burden associates with features suggestive of RHDD in type 2 diabetes and HFpEF cohorts, although independence from generalized adiposity remains unresolved.28,86 EAT may, therefore, contribute to RV diastolic dysfunction via both mechanical constraint (see Extrinsic Influences on RV Diastology) and paracrine inflammation; however, this remains inferential from LV paradigms. Therefore, metabolic contributions to RV diastolic dysfunction are mechanistically coherent but rest almost entirely on rodent models and LV extrapolation. Human RV evidence is limited to indirect imaging surrogates, and no diastolic-specific end points have yet been evaluated with metabolic interventions in human right heart disease.Experimental evidence, from rodent pressure-overload and PH models, implicates sex hormones in RV diastolic adaptation. Estrogen signaling modulation, via Erα (Estrogen receptor alpha) loss-of-function, appears to impair diastolic resilience in pressure-overload models, with sex specific effects.87 Although estradiol supplementation in monocrotaline-induced PH attenuates fibrosis independent of afterload in vitro, with improved RV functional metrics in vivo (which would be expected to preserve compliance).88 Translational difficulty emerges when isolating myocardial from afterload effects of interventions.88 In contrast, androgens appear to promote maladaptive remodeling in rodent isolated pressure-load models, though without demonstrated significant chamber-level hemodynamic impacts.89 Although systemic dehydroepiandrosterone appears to act through pulmonary vascular mechanisms to lower pulmonary pressures, attenuate RV hypertrophy, and reduce PA remodeling.90 These patterns align with human observational associations of sex with prognosis in PH, without direct tissue-level mechanistic confirmation.91 Therefore, any impact on diastolic properties is entirely inferred from rodent models, with no direct human RV tissue confirmation. While the inability to dissociate myocardial from afterload-mediated effects renders the independent diastolic contribution of estrogen and androgen signaling speculative.Myocyte relaxation requires rapid cytosolic Ca2+ clearance via SERCA2a and the Na+/Ca2+ exchanger, permitting actin-myosin detachment.92 Although baseline Ca2+-handling proteins are similar between ventricles, RV myocytes are smaller and exhibit shorter action potentials driven by relatively stronger repolarizing K+ currents, resulting in slower Ca2+ transients.93 In rodent PAH models, pressure loading reduces SERCA2a activity, impairs phospholamban phosphorylation, and causes T-tubule rarefaction.94 These changes produce orphaned RyR2 (Ryanodine Receptor 2) clusters, nonuniform Ca2+ release, diastolic Ca2+ leak, and prolonged relaxation.94–96 T-tubule loss evidence is largely preclinical, and calcium responsiveness varies across human PH phenotypes, which precludes universal RV calcium-cycling defect claims.94–96In human RV septal biopsies from patients with HFpEF, cardiomyocytes display increased calcium sensitivity, which may sustain cross-bridge attachment at lower calcium concentrations and theoretically contribute to diastolic stiffening; this correlated inversely with body mass index, suggesting overlap with metabolic pathways.97 Thus, calcium-handling deficits are well characterized in rodent pressure-overload models, but human RV data are limited to a single HFpEF biopsy cohort with metabolic confounding. The absence of phenotype-stratified studies linking these abnormalities to invasive diastolic indices renders calcium dysregulation a plausible but unvalidated mechanism.Cytoskeletal remodeling increases cardiomyocyte viscoelastic resistance and contributes to impaired relaxation.98 Microtubule depolymerization acutely reduces cardiomyocyte passive viscoelasticity, consistent with improved compliance, as demonstrated in failing human LV tissue.98 This has been corroborated with rodent RV models (both healthy and pressure-loaded); however, direct human RV evidence isolating microtubule-mediated effects remains lacking.99 In human LV tissue, suppression of detyrosinated microtubules speeds relaxation in failing cardiomyocytes, indicating that detyrosination increases viscoelastic resistance that impairs relaxation.100 Cytoskeletal elements and ECM function as an interdependent tensegrity structure determining passive myocardial stiffness in mouse LV tissue.101 Whether similar interactions occur in human myocardium, and how pathological remodeling alters these relationships, remains incompletely understood. RV-specific mechanisms are particularly poorly characterized. Therefore, cytoskeletal stiffening via detyrosinated microtubules is supported by human LV tissue and corroborated in rodent RV models, but no human RV data exist isolating this mechanism. Thus, its role in RV diastolic dysfunction remains inferential.

    Load Phenotypes and Mechanistic Trajectories

    Having outlined the structural and molecular bases of RV compliance, we next examine how defined mechanical loads shape diastolic adaptation. We performed a systematic review of in vivo mammalian models with invasive or imaging assessment of RV diastolic function under controlled loading conditions in accordance with PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines (Supplemental Material).Across 127 models, diastolic abnormalities emerged early across loading types, often preceding or paralleling systolic impairment. Pressure-overload models generated steep EDPVR shifts up with early Tau prolongation. Volume overload produced slower, more variable changes, whereas mixed or experimental disease models accelerated stiffening through added pathogenic injury. Imaging surrogates mirrored invasive indices, although their availability was low. Interpretation is limited by heterogeneous methods, incomplete reporting, and reliance on single time point (terminal) studies. However, the divergence is mechanistically informative: pressure-overload drives rapid intrinsic stiffening through direct myocardial injury, fibrosis, and impaired relaxation. Although volume-overload initially exploits Frank-Starling reserve with diastolic abnormalities emerging later, predominantly via chamber dilatation and interventricular interdependence rather than primary myocardial stiffening. This distinction has direct translational relevance, as pressure- and volume-mediated diastolic dysfunction may warrant different therapeutic strategies. The overall evidence base demonstrated a moderate to high risk of bias alongside substantial heterogeneity in species, instrumentation, and calibration methods. To address this, we assembled heat map trajectories stratified by load type and temporal phase (acute [<1 week], subacute [1–4 weeks], intermediate [1–3 months], chronic [>3 months]), providing a unified visual scaffold for diastolic progression across paradigms (Figure 2, heat map).Heat map table incorporating all 4 model variants (pressure loading, volume loading, mixed (ie, pressure and volume), and experimental disease loading models). Color scheme: Green=preserved or no change. Orange=signal towards abnormality but no robust corroboration (<3 models). Red=evidence for dysfunction across models (≥3 in agreement). Time points: acute ≤1 week. Subacute ≤1 month. Intermediate between 1 and 3 months. Chronic >3 months. ECM indicates extracellular matrix; RAP, right atrial pressure; and RVEDP, right ventricular end-diastolic pressure.Pressure overload produces a rapid rise in filling pressure, early relaxation slowing (prolonged Tau), and EDPVR stiffening.19,102 By the subacute phase, RVEDP increases by 2-fold with a 2-fold prolongation of Tau, while systolic indices remain largely preserved alongside early fibrosis and inflammatory activation.103,104 These changes consolidate subacutely and typically precede overt pump dysfunction, marking early maladaptation.105 A steep rise in EDPVR slope, sustained elevation of RVEDP and RAP (2.5-fold), and elevated Tau (1.7-fold) predominate alongside interventricular effects such as septal bowing and LV underfilling.102,106 Chronic models show a hypertrophic RV with persistent relaxation delay, reduced contractility, and established metabolic and inflammatory remodeling.107,108 Systolic deterioration emerges as stiffness, fibrosis, and wall stress accumulate.89,109 Forward flow declines late and tracks diastolic burden rather than leading it.105 Collectively, these heterogeneous but convergent data sets support a progressive diastolic-to-systolic transition, though temporal precision is limited by scarce serial invasive measurements (Tables S1 and S2).In volume-overload paradigms, RV filling pressures rise early but remain variable, reflective of preload responsiveness rather than fixed diastolic pathology.110 Early diastolic abnormalities are subtle and coexist with Frank-Starling compensation, masking inefficiency.19 The subacute period remains poorly represented, with limited models suggesting accommodation despite rising filling pressures.19,111 Systolic indices are often preserved, but the temporal relationship with diastolic abnormality remains unclear due to limited continuous monitoring.111,112 More durable abnormalities, upward EDPVR shifts, and sustained RVEDP elevation emerge in the intermediate phase, coinciding with fibrosis and ECM remodeling.111,112 In large animal shunt and regurgitation models with serial invasive P-V analysis, RVEDP rises 2.4-fold at intermediate stages and 2.5-fold chronically, accompanied by upward displacement and steepening of the EDPVR.111,113 Interventricular interdependence predominates, as chamber dilatation alters septal position and pericardial constraint, reducing LV compliance and preload reserve and suggesting biventricular coupling, rather than isolated RV stiffness, drives clinical deterioration.106,114 Most studies lack simultaneous RV-LV P-V acquisition, leaving exact timing uncertain, and temporal relationships between diastolic stiffness and systolic dysfunction remain inferential (Tables S3 and S4).110,113Mixed loading paradigms, where pressure and volume loading conditions are applied, remain sparsely characterized. In acute and early subacute models, RVEDP increases ≈1.9-fold relative to unloaded controls, alongside blunting of compliance.115,116 Interventricular impacts emerge early, with restricted LV filling seen at an earlier stage than that seen in isolated load states.115,116 Systolic indices fall at relatively modest cumulative loads yet are difficult to interpret as rising RV afterload and falling LV preload distort standard contractility indices.115,116 Truly chronic invasive RV P-V data under combined dual loading conditions are absent. Overall, the available data are fragmented with few models, limited time points, and virtually no chronic invasive tracking. It is uncertain whether combined loading represents a distinct biological entity or simply an accelerated version of single load remodeling (Tables S5 and S6).115,116Experimental disease models attempt to harmonize mechanical load with human pathophysiology. In models mimicking PH (monocrotaline, Su-Hx, Chronic hypoxia), a consistent diastolic pattern emerges, with elevated RVEDP, slowed relaxation, and steepened EDPVR.102,117 These changes mirror pressure-overload banding but occur at lower afterload, indicating that biological injury, rather than load alone, accelerates maladaptation.19,117,118 For example, proinflammatory cytokine cascades (TNF-α [tumor necrosis factor-α], IL [interleukin]-6, TGF-β [transforming growth factor β]) activate fibroblast proliferation and accelerate ECM remodeling independent of hemodynamic load itself, embedding structural stiffness that persists even if afterload is relieved (see Fibrosis, Extracellular Matrix Remodeling [Validated]).19,117 Concurrently, titin N2B hypophosphorylation, demonstrated in both PAH animal models and human biopsy data, increases intrinsic cardiomyocyte passive stiffness and is linked to hypertrophic signaling via the N2BA-MARP axis, suggesting that diastolic stiffening and maladaptive hypertrophy may share a common molecular trigger (see Titin Isoforms and Passive Elasticity [Validated]). In contrast, volume-overload biology is less well characterized, with ECM changes appearing later and titin isoform shifts favoring the compliant N2BA splice variant, consistent with the slower trajectory of diastolic deterioration observed in these models. These mechanisms contribute to stiffness that would otherwise remain partly reversible in pure mechanical models.115 Thus, pressure sets the stage, but disease biology determines how rapidly and irreversibly maladaptation becomes embedded.117 Outside PAH, data for sepsis, ischemic, tetralogy of Fallot, and metabolic paradigms remain sparse and largely hypothesis-generating (see Supplemental Material for further discussion; Tables S7 and S8).

    Invasive Parameters to Measure Right Heart Diastology, Current Status

    Having outlined the physiological basis of Tau, β, EDPVR, Eed (end-diastolic elastance), and RVEDP in Foundational Physiology and Anatomy, we now consider their validation in human studies and their translational relevance (Table 3).Current Utility of Available Invasive RV Diastolic MetricsAmong invasive indices, RVEDP is the most widely measured because of its simplicity and routine acquisition during right heart catheterization.9,17 As explained in section Foundational Physiology and Anatomy, RVEDP reflects preload, pericardial constraint, and ventricular interdependence rather than intrinsic stiffness; thus, it is poorly specific for intrinsic RV diastolic dysfunction.6,26,119–121 Although prognostically relevant in PH and HF, it functions primarily as a crude hemodynamic marker rather than a mechanistic index.Tau quantifies active relaxation, reflecting lusitropic efficiency. Reference ranges for RV Tau are unknown.9,19,122 Measurement requires micromanometry and is complicated by the RV’s rapid pressure decay and load sensitivity.9,122 Based on LV and preclinical data, normal Tau is assumed to be ≈30 to 40 ms and is prolonged in PAH, indicating delayed calcium reuptake and cross-bridge detachment.18,44. Reproducible human measurements are challenging, and no reference ranges or data sets exist.Similarly, for EDPVR, no human reference ranges exist.9,19,44 Its measurement requires P-V loops, via conductance catheters, limiting accessibility.9 RV geometry complicates volume estimation, and small errors in zero referencing markedly affect EDPVR slope. Existing data sets are typically phenotypically homogenous and limit translational utility.β, derived from the EDPVR, provides a quantitative expression of passive stiffness.6,9 It is elevated in PAH, correlates with filling pressures, exercise intolerance, and adverse outcomes, and integrates myocardial, pericardial, and vascular contributions to chamber behavior.44,52 Nevertheless, its measurement remains technically demanding, sensitive to load, and limited to small physiological and PH studies, with no normative data sets.Eed as a single-beat estimate of diastolic stiffness can be derived from instantaneous P-V data, making it more feasible for serial human assessment.9 Elevated Eed reflects a stiffer ventricle at end-diastole and correlates with disease severity, lower stroke volume, and higher RA pressure in PAH.4,44 Importantly, Eed falls in therapeutic responders, preceding improvements in RV-PA coupling, suggesting it may detect reversible diastolic stiffness.4 However, normative values and reproducibility remain undefined, and load sensitivity complicates single time point interpretation.

    Imaging Toolkit: Current State of Validation for Available Noninvasive Measures

    Most patients at risk of, or diagnosed with, right-sided heart disease will never undergo high-fidelity right heart catheterization. Translating invasive diastolic physiology into scalable, reproducible, noninvasive indices is therefore essential for clinical implementation. Echocardiography and cardiac magnetic resonance imaging (CMR) provide a broad toolkit for this purpose. Below, we critically appraise the validation status of available noninvasive metrics of right heart diastology and formulate a minimal clinical data set, delineating where evidence supports clinical application and where methodologic gaps persist (Table 4 [Echocardiography], Table 5 [CMR]).Minimal Clinical Data Set (Pragmatic Clinical and Echocardiographic Assessment), With Normal RV Systolic FunctionDiscriminative Phenotyping Using CMR, Most Useful in Patients With Indeterminate ScreeningThe American Society of Echocardiography has recently published detailed guidelines for ultrasound-based assessment of the right heart.29 Regarding RV diastolic dysfunction, these emphasize right heart morphology, transtricuspid inflow velocities, tissue Doppler imaging–based annular velocities, and hepatic vein flow patterns, while noting that assessment is affected by age, sex, respiratory rate, and heart rate. Many indices, however, remain difficult to implement clinically (Table 4).Routine 2-dimensional and 3-dimensional echocardiography allows area and volumetric assessment of right‐heart preload and atrial compliance. Indexed RA area and volume correlate strongly with invasive RA pressure and RVEDP in small disease (PH, HF) cohorts and independently predict outcomes.2,34,36,37,123,124 Although 3-dimensional imaging improves accuracy and the WASE study (World Alliance Societies of Echocardiography) provides normative ranges, limited multicenter calibration and prognostic thresholds prevent consistent clinical adoption.125 Despite strong conceptual appeal, 3-dimensional RA emptying fraction lacks invasive validation, and evidence derives mainly from CMR data sets.30,33,126Spectral Doppler and tissue Doppler imaging provide noninvasive surrogates of RV filling pressures. The tricuspid E/A ratio shows moderate correlations with invasive RAP.123,127 However, it lacks evidence of prognostic significance, and reference values come from small, healthy cohorts.10,128 Accuracy is limited by age, rhythm, and respiratory effects. Deceleration time correlates only modestly with RAP and RVEDP.123 It unfortunately lacks validation against Tau (or other physiological correlate) and has unknown prognostic utility.10,128 Both metrics remain load-sensitive surrogates constrained by limited standardization and are supportive rather than diagnostic. The tricuspid annular early diastolic velocity e′, measured by tissue Doppler imaging, reflects intrinsic RV myocardial relaxation.129 Conceptually analogous to mitral e′ on the left, this is a surrogate of lusitropy but is load-dependent with substantial interobserver variability.129,130 Alone, it correlates weakly with invasive pressures; its primary utility is within E/e′, which modestly approximates filling pressures.14,129–131 Across heterogeneous cohorts, E/e′ loses accuracy at higher RAPs and lacks multicenter calibration.129,131 Disappointingly, E/e′ does not demonstrate good correlation with other diastolic parameters (such as Eed).14Thus, although guideline-endorsed, E/e′ remains inconsistently reliable. Right-sided IVR time, measured by spectral Doppler, correlates with invasive RAP and RVEDP but not directly with Tau.123 Prognostic data and cross-platform reproducibility are lacking; thus, it remains a physiological descriptor with limited clinical validation.29,123Overall strain quantifies global tissue deformation using speckle-tracking echocardiography. RA reservoir strain (RASr) correlates with invasive RAP/RVEDP.13,36 In PH, RASr correlates inversely with RVEDP and Eed and has shown independent prognostic value.30,34–36 However, validation outside PH is limited, reference ranges remain broad, and limited external validation and vendor harmonization preclude standardized cutoffs and widespread uptake.132 RA conduit (RA conduit strain) and booster strain lack robust invasive validation. Available data show inconsistent correlations and no independent prognostic value.35 Unfortunately, strain itself is inherently load-dependent, which limits its utility as a diastolic tool. Strain rate quantifies deformation velocity, and this may be applied to atrial phasic function. Reference ranges in healthy populations exist.133 In human PH cohorts (CTEPH specifically), when combined with indexed RA area, it diagnoses RV diastolic dysfunction with reasonable accuracy.134 However, strain-rate reproducibility is inferior to strain, and vendor variability limits standardization.133 Finally, although 3-dimensional strain measures exist, significant feasibility constraints limit current utility.135 Technological advances allowing more universal feasibility, multicenter calibration, and prognostic validation are needed before clinical adoption can be widespread.Where single echocardiographic metrics fail, composite measures may be useful. Two examples emerge; the S′/RAAi ratio (lateral tricuspid annular systolic velocity divided by indexed RA area) has been validated against conductance catheter-derived Eed in PH populations (area under the curve, 0.91).14 It independently predicts mortality in precapillary PH.14 This metric’s strength lies in simplicity, requiring only routine tissue Doppler imaging and 2-dimensional measurements, and validation beyond PH populations is awaited.14 Second, RA stiffness is assessed through division of RAP (estimated via transtricuspid E/e′) by RASr, which correlates well with functional deterioration in small, well-phenotyped cohorts; however, this lacks invasive validation.136 Despite the added complexity of speckle-tracking imaging, there is translational promise, pending validation in clinical cohorts.Systemic venous interrogation provides indirect surrogates of right-sided filling pressures. Inferior vena cava (IVC) diameter/collapsibility correlates with invasive RAP and underpins American Society of Echocardiography categories.29 However, accuracy markedly declines in ventilated or volume-altered states.123,130 Compounded by limited reproducibility data and variability from respiration, position, and tricuspid regurgitation.29,123 Despite these caveats, IVC assessment remains clinically useful. Hepatic vein flow profiles mirror RAP but lack demonstrated prognostic value.123,129,130 Composite frameworks, such as the Venous Excess Ultrasound Score, have gained popularity by integrating IVC dilation with Doppler abnormalities.137 Higher Venous Excess Ultrasound Score grades correlate with elevated venous pressure and adverse consequences, offering a holistic assessment of systemic congestion.137 Emerging data indicate that natriuretic peptide trajectories parallel Venous Excess Ultrasound Score grades, suggesting biomarkers may play a role in monitoring decongestive responses and chamber coupling.137CMR extends diastolic assessment beyond echocardiography by directly quantifying atrial and ventricular filling mechanics with high spatial resolution. CMR feature tracking–derived RARs are well validated in PH.30 While in HF phenotypes, CMR-derived impaired RASr, RA conduit strain, independently predicts outcomes.126,138 Despite consistent physiological coherence, reproducibility, and thus external validity are limited by temporal resolution constraints, vendor algorithm heterogeneity with limited reference range harmonization and by field strength variability.139 RA emptying fractions, calculated from volumetric analysis, demonstrate reservoir, conduit, and booster contributions to RV filling. These correlate indirectly with mean RAP in PH cohorts and show emerging prognostic associations in HF populations, but methods remain heterogeneous across centers.33,138 Volumetric coupling ratios extend this framework by relating atrial to ventricular volumes. The right atrioventricular coupling index (RA minimum volume divided by RV end-diastolic volume) increases progressively with rising Eed in precapillary PH, reflecting disproportionate RA dilatation.31 This metric operationalizes the concept of RA adaptation disproportionately to the RV, although prognostic validation against outcomes remains needed. Beyond atrial measures, RV diastolic volume-time curves and related indices of early filling offer conceptual linkage to relaxation and compliance.39 However, direct invasive validation and multicenter reproducibility are limited (Table 5).Regarding advanced CMR techniques, RV tissue mapping has strong direct evidence. In PH-HFpEF, extracellular volume with high-resolution T1 mapping correlates significantly with RV diastolic stiffness.140 Unfortunately, in PAH, significance has not been demonstrated.140 Longitudinal data in human CTEPH indicate Eed may normalize with afterload reduction even when RV extracellular volume remains elevated, suggesting a dissociation between ECM remodeling and chamber stiffness after afterload relief.141 By contrast, direct validation of intracardiac 4-dimensional flow metrics against RV Eed or β remains limited.142 Four-dimensional flow–derived PA wall shear stress correlates with invasive hemodynamics and vascular stiffness in PH, supporting PA stiffness assessment but not direct evaluation of RV myocardial stiffness.142

    Applying Right Heart Diastology to Human Health and Disease

    Having established the physiological framework of right heart diastology, measurable invasive and noninvasive correlates clearly exist in humans. Across disease states, however, a landscape emerges where abnormalities in relaxation (Tau), compliance (steeper EDPVR, higher diastolic stiffness constant [B]/Eed), and filling pressures are likely present yet frequently undetected. Outside of PAH, invasive data from human studies remain limited, normative ranges are undefined, and most indices are heavily load-dependent. We examine how RV diastolic dysfunction manifests across major pathologies.PH provides the clearest human demonstration that right heart diastology is a coupling disorder rather than single-chamber pathology.4,44 On invasive studies, a consistent pattern emerges as active relaxation slows (prolonged Tau) and passive stiffness rises (steeper EDPVR, increased β) before overt contractile failure.3,44 Single-beat Eed captures reversible components of this stiffening and improves with effective PAH therapy, whereas β and RVEDP carry independent prognostic value in small cohorts.4,44,52 These ventricular changes are accompanied by characteristic RA remodeling.30,31 As RV stiffness rises, phasic RA function attenuates an early signal of a diastolic unit under stress.13,30,31 Across PH cohorts, RASr correlates with invasively measured RAP and RVEDP and may detect early diastolic dysfunction before clinical decompensation.13,30 The collapse of atrial compensation, reflected in rising RAP, carries robust prognostic weight across cohorts.2,13,32In left-sided HF, the RV remodels within a constrained system defined by pericardial and septal interactions.119,143,144 Yet, direct invasive assessment of RV diastolic mechanics remains rare even in academic settings; our understanding is largely inferred from filling pressures alone.9,121 The limited invasive data available suggest HF follows a similar diastolic trajectory to PH.145 In HFpEF, RV diastolic stiffness is markedly elevated (RVEDP 12.4±4.1 versus 5.6±1.9 mm Hg in controls during exercise) with impaired relaxation (Prolonged Tau, 41±11 versus 27±8 ms), and emerges before the presence of systolic dysfunction.145 Echocardiographic and CMR-derived RA phasic function independently predict hospitalization and mortality in HF cohorts, suggesting prognostic signals attributed to right heart dysfunction may reflect diastolic and atrial contributions beyond systolic impairment alone.126,146 If the above PH paradigm extrapolates, diastolic indices validated in pulmonary vascular disease may serve as early warning signals in HF, detecting maladaptive remodeling before overt systolic decline. Validating this hypothesis in existing HF cohorts is a critical next step toward embedding right heart diastolic assessment in outcome-driven care.Biventricular adult congenital heart disease provides natural experiments that validate the loading-dependent framework established in animal models (Load Phenotypes and Mechanistic Trajectories) and PH (single-ventricle physiology represents a distinct substrate beyond this review’s scope).5,20,144 Pressure-loaded lesions follow a predictable trajectory. In isolated pulmonary stenosis, the RV sustains chronically elevated afterload with preserved systolic output but almost invariably develops diastolic dysfunction, manifesting as progressive RA enlargement and loss of reservoir function rather than overt pump failure.5,48,144 These patients demonstrate that diastolic impairment may be the dominant mode of clinical deterioration in the pressure-loaded RV. Although in Eisenmenger physiology, the RV often preserves systolic function into late adulthood, likely because it has never detrained from systemic or near-systemic pressures, illustrating how lifelong conditioning provides unique conditioning, preserving RV-PA coupling and delaying the transition from adaptive hypertrophy to maladaptive stiffness.5,48,144 Pure volume loading tells a different story. Unrepaired atrial septal defects and partial anomalous pulmonary venous return seldom progress to RV failure, showcasing the chamber’s capacity to accommodate large stroke volumes with preserved compliance when conditioned from early life.5,20,111–113,144 Repaired tetralogy of Fallot represents a more complex, mixed phenotype: early pressure-overload, chronic postoperative pulmonary regurgitation, and surgical scar combine to produce regional dysfunction, fibrosis, and diastolic stiffening despite apparently preserved ejection fraction.5,43,147,148 Invasive data confirm that RVEDP and RAP independently predict adverse outcomes, with disproportionate rises in filling pressure for a given regurgitant volume reflecting increased chamber stiffness.149 Here, diastolic assessment may provide prognostic clarity where systolic metrics fall short.150Taken together, these biventricular adult congenital heart disease phenotypes provide real-world human data that complement the mechanistic and invasive data discussed earlier. Chronic pressure-load drives hypertrophy, rising β/Eed and RA remodeling. While pure volume load is often well tolerated with preserved compliance, chamber and pericardial interactions exert greater influence. These natural experiments underscore that right heart diastology is fundamentally a reflection of loading history across the diastolic unit, rather than an intrinsic property of any single chamber. Integrating RA phasic behavior, RV compliance, and pulmonary vascular load, into a unified schema may help prognosticate, guide risk stratification, personalize surveillance, and provide mechanistic scaffolds for emerging therapeutic strategies.

    Future Directions

    Despite recent advances, right heart diastology remains a conceptual frontier with substantial methodological challenges. Its physiological relevance is no longer in doubt, yet core definitions, measurement frameworks, and mechanistic hierarchies remain fragmented or extrapolated. To address this, we propose a tiered diagnostic framework and preliminary grading system, designed to guide future validation studies and establish RHDD as a standardized diagnostic entity.The clinical translation of right heart diastology faces 4 convergent barriers that collectively explain why mechanistic understanding has outpaced bedside application.First, load dependence pervades every available metric (see Invasive Parameters to Measure Right Heart Diastology, Current Status). Invasive indices thus conflate intrinsic myocardial properties with extrinsic hemodynamic conditions, compounded by the RV itself, where low absolute pressure magnifies the proportional impact of small errors.Second, methodological variability limits comparability (Invasive Parameters to Measure Right Heart Diastology, Current Status and Imaging Toolkit: Current State of Validation for Available Noninvasive Measures). Invasive assessment requires high-fidelity micromanometry or conductance catheterization, techniques with no standardized acquisition protocols and confined to specialized centers. Although noninvasive surrogates suffer from vendor heterogeneity, technical availability, and limited interobserver reproducibility, as detailed in sections Invasive Parameters to Measure Right Heart Diastology, Current Status and Imaging Toolkit: Current State of Validation for Available Noninvasive Measures.Third, imaging constraints remain substantial. RA and RV geometry present a significant translational challenge for conventional and speckle-tracking echocardiography, temporal resolution limits diastolic phase discrimination, and reference ranges for new or emerging metrics are lacking.Fourth, and most critically, outcome-linked validation is absent for the constructs proposed in this review. While individual metrics (RASr, Eed, right atrioventricular coupling index) show physiological coherence and disease severity correlations in small, predominantly PAH cohorts, no study has demonstrated that a composite diastolic unit assessment has prognostic importance beyond established single-chamber indices such as RV systolic function or RAP. Until these barriers are addressed through prospective, multisite studies with prespecified diastolic end points, the proposed framework remains a research scaffold rather than a validated clinical tool.We propose a 3-tiered assessment framework for diagnosing RHDD, anchored to the assessing RA-RV-PA diastolic unit (Tables 4 through 6, utilizing Figure 3 as workflow).Workflow for right heart diastolic assessment. RHDD indicates right heart diastolic dysfunction.Tier 1 (screening, Table 4) employs echocardiography for pragmatic clinical application, capturing RA structure, phasic function, estimated RAP, RV compliance surrogates, and available RA-RV coupling indices assessing coupling efficiency and stress.Tier 2 (phenotyping, Table 5) leverages CMR for mechanistic characterization when tier 1 is indeterminate, including tissue characterization (with extracellular volume quantification), gold-standard chamber assessment, and high-resolution strain validation.Tier 3 (confirmation, Table 6) utilizes invasive P-V analysis as the reference standard, linking chamber-level indices (Eed, β, Tau) to molecular mechanisms outlined in section Microscopic Understanding of Diastole and Difference Between Ventricles.Invasive Assessment With Mechanistic CorrelationBuilding on this data set, we propose a 4-grade classification reflecting progressive diastolic unit failure understood through chamber interaction (Table 7).Grading Based on the Diastolic Unit Concept and Progression of Abnormality Outlined in Section Right Heart Coupling Axes, Understanding the Diastolic Unit (RA-RV-PA), Alongside Best Estimates of Detectable Abnormalities Across ModalitiesGrade 0 (normal) shows preserved (normal) RA function and structure.Grade I (impaired relaxation) demonstrates early RV lusitropic impairment (impaired RA conduit strain) with intact atrial compensation (preserved RASr).Grade II (reduced compliance) shows structural RA adaptation (reduced RASr, RA enlargement) to a stiffening RV, signaled by deteriorating coupling reserve (declining S′/indexed RA area, abnormal coupling metrics with stress).Grade III (uncoupled/restrictive) shows severely impaired RA function (elevated RAP, abnormal RASr) and RA-RV uncoupling.This grading system is proposed as a conceptual scaffold requiring prospective validation, not as established clinical guidance.We think that 5 actionable priorities emerge directly from the evidence gaps identified in this review:Diagnostic thresholds for RA-RV coupling metrics must be derived against invasive reference standards (Invasive Parameters to Measure Right Heart Diastology, Current Status and Imaging Toolkit: Current State of Validation for Available Noninvasive Measures). The proposed grading system (Table 7) relies on RA phasic strain and coupling indices for which no validated cutoffs currently exist. Prospective studies pairing simultaneous echocardiographic RA strain and coupling ratios with conductance catheter-derived Eed and β, across at minimum PAH and HFpEF phenotypes, are required to determine whether these indices reliably discriminate RHDD grades and provide incremental prognostic value, beyond measuring RV systolic function.Studies to show whether RA functional metrics detect diastolic deterioration before resting RV-PA uncoupling. The section Right Heart Coupling Axes, Understanding the Diastolic Unit (RA-RV-PA) positions the RA reservoir and booster dysfunction earlier on the remodeling trajectory than ventricular uncoupling. Serial imaging studies should explore whether RA phasic changes precede Ees/Ea deterioration temporally and whether this earlier signal identifies a modifiable therapeutic window.Mechanistic pathways require validation beyond PAH with human RV tissue. Of the 8 molecular mechanisms reviewed in section Microscopic Understanding of Diastole and Difference Between Ventricles, only fibrosis, titin hypophosphorylation, and blunted β-adrenergic signaling are supported by human RV data, almost exclusively from PAH explants. RV tissue from HFpEF-PH, congenital heart disease, and CTEPH cohorts, for example, would establish which mechanisms are disease-universal versus phenotype-specific when tissue sample results are linked to contemporaneous invasive and imaging phenotyping.Multisite reproducibility for strain-based diastolic indices should be established. RA strain and strain-rate measurements lack vendor harmonization, standardized reference ranges, and multicenter reproducibility data (Imaging Toolkit: Current State of Validation for Available Noninvasive Measures).Outcome-linked validation of the integrated diastolic unit hypothesis has not yet been established. Although individual metrics, such as RASr, Eed, and right atrioventricular coupling index, are physiological and correlate with disease progression in predominantly PAH cohorts, prospective data demonstrating incremental prognostic value beyond established indices (eg, RV systolic function or RAP) are not yet available. Addressing this through multicenter, prospectively designed studies with prespecified diastolic end points represents the next step in translating our framework from physiological modeling to clinical application.

    Conclusions

    Right heart diastology is not merely a mirror of left-sided physiology. It is a distinct, coupled, load-sensitive process with prognostic and therapeutic relevance across multiple diseases. The framework proposed here, grounded in RA phasic function as the clinical window into RV compliance, offers a testable scaffold for the prospective studies that will be required to translate mechanistic insights into standardized clinical assessment. If right heart diastology is fundamentally a coupling disorder, as the evidence reviewed here suggests, our diagnostic frameworks reflect that architecture.

    Article Information

    None.
    AHDr. Anna Hemnes

    Dr. Anna Hemnes

    Pulmonology & Critical Care · Pulmonary Vascular Medicine
    Vanderbilt Health
    annahemnes